Abstract: From one of an inspection image of a printed material and a reference image, a predetermined area including an edge is extracted and a pixel value of a pixel is corrected, which configures the predetermined area in the inspection image or the reference image, from which the predetermined area has been extracted, and a blot on the printed material is detected by using collation results of the corrected inspection image and the reference image and a threshold value, or by using collation results of the inspection image and the corrected reference image and the threshold value.

Abstract: In an inspection system including a printing apparatus, an inspection apparatus configured to inspect quality of a printed product printed by the printing apparatus, and an information processing apparatus configured to transmit a print job to the printing apparatus, the information processing apparatus transmits a print job to the printing apparatus in a case where a reference image to be used for inspecting the quality of the printed product corresponding to the print job is registered, and does not transmit the print job in a case where the reference image corresponding to the print job is not registered.

Abstract: In an inspection system including a printing apparatus, an inspection apparatus configured to inspect quality of a printed product printed by the printing apparatus, and an information processing apparatus configured to transmit a print job to the printing apparatus, the information processing apparatus transmits a print job to the printing apparatus in a case where a reference image to be used for inspecting the quality of the printed product corresponding to the print job is registered, and does not transmit the print job in a case where the reference image corresponding to the print job is not registered.

Abstract: In an inspection system including a printing apparatus, an inspection apparatus configured to inspect quality of a printed product printed by the printing apparatus, and an information processing apparatus configured to transmit a print job to the printing apparatus, the information processing apparatus transmits a print job to the printing apparatus in a case where a reference image to be used for inspecting the quality of the printed product corresponding to the print job is registered, and does not transmit the print job in a case where the reference image corresponding to the print job is not registered.

Abstract: In an inspection system including a printing apparatus, an inspection apparatus configured to inspect quality of a printed product printed by the printing apparatus, and an information processing apparatus configured to transmit a print job to the printing apparatus, the information processing apparatus transmits a print job to the printing apparatus in a case where a reference image to be used for inspecting the quality of the printed product corresponding to the print job is registered, and does not transmit the print job in a case where the reference image corresponding to the print job is not registered.

Abstract: A cyclic amine derivative represented by a general formula (I) or a pharmacologically acceptable salt thereof: wherein n represents 1 or 3, R1 represents an alkyl group having 1 to 6 carbon atoms unsubstituted, substituted with a halogen atom or substituted with an alkyloxy group having 1 to 4 carbon atoms and R2 represents a hydrogen atom or a halogen atom.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by general formula or a pharmacologically acceptable salt thereof: A method of treating neuropathic pain includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal. A method of treating fibromyalgia syndrome includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by general formula or a pharmacologically acceptable salt thereof A method of treating neuropathic pain includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal. A method of treating fibromyalgia syndrome includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal.

Abstract: A cyclic amine derivative represented by a general formula (I) or a pharmacologically acceptable salt thereof: wherein n represents 1 or 3, R1 represents an alkyl group having 1 to 6 carbon atoms unsubstituted, substituted with a halogen atom or substituted with an alkyloxy group having 1 to 4 carbon atoms and R2 represents a hydrogen atom or a halogen atom.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

Abstract: A method relieves both nociceptive pain and neuropathic pain and has fewer side effects. The compound includes cyclohexane derivatives represented by the following compound, or pharmaceutically acceptable salts thereof or prodrugs thereof.

Abstract: A method relieves both nociceptive pain and neuropathic pain and has fewer side effects. The compound includes cyclohexane derivatives represented by the following compound, or pharmaceutically acceptable salts thereof or prodrugs thereof.

Abstract: A compound has a strong analgesic action against both nociceptive pain and neuropathic pain and has less side effects, and is medically useful. The compound includes cyclohexane derivatives represented by the following compound, or pharmaceutically acceptable salts thereof or prodrugs thereof.

Abstract: A compound has a strong analgesic action against both nociceptive pain and neuropathic pain and has less side effects, and is medically useful. The compound includes cyclohexane derivatives represented by the following compound, or pharmaceutically acceptable salts thereof or prodrugs thereof.